Compound details
Sanggenon O
| Compound ID | CDAMM02638 |
|---|---|
| Common name | Sanggenon O | IUPAC name | 4-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-1,3,5a,8-tetrahydroxy-10a-(3-methylbut-2-enyl)-[1]benzofuro[3,2-b]chromen-11-one |
| Molecular formula | C40H36O12 |
| Retention time | 23 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 709.222 | Theoretical mz | 709.228 |
| Error | 8.57 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.9966 |
| Inchi key | LHPRLOAEYJFDCW-NPFGZEBFNA-N |
|---|---|
| Smiles | O=C(C1=CC=C(O)C=C1O)C2C(C=C(C)CC2C3=CC=C(O)C=C3O)C=4C(O)=CC(O)=C5C(=O)C6(OC7=CC(O)=CC=C7C6(O)OC54)CC=C(C)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | Diarylheptanoids |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |